About PharmaRoz

PharmaRoz brings the US FDA's regulatory record for Indian pharma companies into one free, searchable place — plant by plant, with a link to the original source on every record.

Indian pharma companies supply a large share of the generic medicines used in the United States. A USFDA inspection result, a Form 483, a warning letter or an import alert can change a company's US business. These records are public, but they are spread across several FDA databases and company stock-exchange filings. PharmaRoz collects them automatically, matches each plant to its listed company, and shows the full history in plain language.

What we cover

• USFDA inspection classifications (NAI, VAI, OAI) for Indian plants
• Form 483 observations recorded in FDA's inspection data
• FDA warning letters and import alerts (Import Alert 66-40)
• New US approvals (ANDA/NDA) for listed Indian companies
• Company filings on BSE about USFDA inspections and approvals

What we don't do

We do not give investment advice, stock tips, ratings, targets or recommendations. We report public regulatory facts and past events. See the disclaimer.

Contact

Corrections and feedback: contact@pharmaroz.com. If you spot an error, tell us — we fix it and record the change on the corrections section.